Medite Cancer Diagnostics Inc. logo

Medite Cancer Diagnostics Inc. (MDIT)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
8.67K Market Cap
- P/E Ratio
- Div Yield
88 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track MDIT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MDIT closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, MDIT stock gained 0%.
MDIT is not paying dividends to its shareholders.
The last earnings report, released on Feb 28, 2024, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0158%, based on the last three reports.
Medite Cancer Diagnostics Inc. has completed 2 stock splits, with the recent split occurring on Mar 12, 2015.
The company's stock is traded on one exchange.

MDIT Chart

People also search for

WM Technology, Inc.
$ 0.42
+0.6024%
Realbotix Corp.
$ 0.22
+4.8333%
Luna Innovations Incorporated
$ 1.27
0%
Marpai Inc.
$ 2.16
-1.3699%
Argo Corp.
$ 0.24
-0.6723%

Medite Cancer Diagnostics Inc. (MDIT) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Medite Cancer Diagnostics Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is MDIT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 8.67K.

Has Medite Cancer Diagnostics Inc. ever had a stock split?

Medite Cancer Diagnostics Inc. had 2 splits and the recent split was on Mar 12, 2015.

Medite Cancer Diagnostics Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Rahsan-Rahsan Lindsay CEO
OTC PINK Exchange
58503D200 CUSIP
US Country
69 Employees
- Last Dividend
28 Nov 2007 Last Split
- IPO Date

Overview

Medite Cancer Diagnostics, Inc. is a forward-thinking medical technology company based in Orlando, Florida. It is dedicated to advancing the field of cancer diagnostics through the development, manufacturing, and marketing of innovative molecular biomarkers, medical devices, and consumables. These products are focused on the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. With a global reach, Medite Cancer Diagnostics serves histology and cytology laboratories found in hospitals, research institutions, and independent labs across the United States, China, Europe, and North Africa. This broad market presence is supported through both direct sales and an extensive network of distributors.

Products and Services

  • USE 33: An ultrasonic decalcification instrument designed to automatically run the decalcification process under controlled temperatures, improving the quality and efficiency of sample preparation.
  • TPC 15 Duo and Trio: Tissue processing instruments that enhance the preparation of tissue samples by providing reliable, high-throughput capabilities.
  • TES 99 and TES Valida: Cooling units that are essential for the preservation and preparation of tissue samples, ensuring they remain at optimal temperatures throughout processing.
  • M530, A550, M380 Microtomes: A series of microtomes for precise tissue sectioning, catering to various laboratory needs. These devices allow for thin sectioning of tissue samples, crucial for accurate histological analysis.
  • M630 Freezing Microtome: A specialized microtome designed for the freezing sectioning of tissue samples, facilitating rapid processing and examination of specimens.
  • TST44: A robotic multi-staining system that automates the staining of tissue samples, significantly increasing throughput and consistency in histology labs.
  • COT 20: A linear staining system that provides an efficient solution for the manual staining of tissue samples, offering flexibility and reliability.
  • RCM 9000, ACS 720, and TWISTER Robotic Coverslippers: A range of robotic coverslippers designed to automate the coverslipping process, enhancing both the speed and quality of slide preparation.
  • SoftKit: An innovative device for the self-collection of samples by patients. These samples can be evaluated to provide a comprehensive assessment of the health of the entire female genital tract, broadening the scope of preventive care and early detection of diseases.

Contact Information

Address: 10524 Moss Park Road
Phone: 407-996-9630